Baird Medical Investment Holdings (BDMDW) Liabilities and Shareholders Equity (2023 - 2025)

Baird Medical Investment Holdings has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $69.7 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 10.6% year-over-year to $69.7 million; the trailing twelve-month figure through Dec 2025 stood at $224.7 million (changed N/A YoY), and the FY2025 full-year result was $69.7 million, down 10.6% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $69.7 million, down from $77.0 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $78.0 million in Q4 2024, with the low at $56.7 million in Q4 2023.
• Average Liabilities and Shareholders Equity over 3 years is $70.3 million, with a median of $73.3 million recorded in 2025.
• Year-over-year, Liabilities and Shareholders Equity jumped 37.48% in 2024 and retreated 10.6% in 2025.
• Tracing BDMDW's Liabilities and Shareholders Equity over 3 years: stood at $56.7 million in 2023, then surged by 37.48% to $78.0 million in 2024, then decreased by 10.6% to $69.7 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $69.7 million (Q4 2025), $77.0 million (Q2 2025), and $78.0 million (Q4 2024), per Business Quant data.

Peer Comparison